Aehr Test Systems
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AEHR research report →
Range $110 – $175
Price Chart
About the company
Aehr Test Systems, founded in 1977 and based in Fremont, California, specializes in the global provision of advanced burn-in and test systems for integrated circuits, encompassing logic, optical, and memory devices. Its extensive product lineup includes the ABTS and FOX-P families of test and burn-in solutions, complemented by specialized components such as the FOX WaferPak Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier, and FOX DiePak Loader. The ABTS system is specifically designed for both production and qualification assessments of packaged parts, covering a range of lower and higher power logic devices, as well as various memory types.
- CEO
- Gayn Erickson
- IPO
- 1997
- Employees
- 138
- HQ
- Fremont, CA, US
Get TickerSpark's AI analysis on AEHR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.31B
- P/E
- 830.20
- Fwd P/E
- 42.45
- PEG
- 17.65
- P/S
- 22.24
- P/B
- 7.27
- EV/EBITDA
- 649.21
- Div Yield
- 0.00%
- Gross Margin
- 40.57%
- Op Margin
- -5.54%
- Net Margin
- 2.93%
- ROE
- 1.20%
- ROIC
- 1.88%
Latest fiscal year · YoY change
- Revenue
- $50.00M-15.2%
- Gross Profit
- $17.65M-26.2%
- Op Income
- $-14,149,000
- Net Income
- $-7,126,000-82.3%
- EPS
- $-0.23-76.9%
- OCF Growth
- +55.3%
- FCF Growth
- +56.6%
- 52W High
- $147.40
- 52W Low
- $18.70
- 50D MA
- $74.60
- 200D MA
- $76.39
- Beta
- 3.33
- RSI (14)
- 38
- Avg Volume
- 2.73M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Aehr delivered a record first quarter, raised full-year guidance to $150 million, and said AI/data center demand is broadening across both wafer-level and package-level burn-in.· November 2, 2026
- Record Q1 revenue of $33 million, up 200% year over year and 75% sequentially, with non-GAAP net income of $9.4 million.
- Bookings were $46.7 million, producing a 1.4 book-to-bill, and effective backlog reached $109.3 million as of November 1.
- Management raised fiscal 2027 revenue outlook to $150 million from a prior range of $130 million to $150 million and expects non-GAAP net income at least 20% of revenue.
- Gross margin expanded to 48.5% from 37.5% last year, helped by higher volume and a better product mix.
- The company highlighted multiple growth vectors: AI processors, silicon photonics, silicon carbide, GaN, and emerging HBM opportunities.
First-quarter fiscal 2027 revenue was a record $33 million, up 200% year over year from $11 million and up 75% sequentially. Non-GAAP net income was $9.4 million, or $0.28 per diluted share, versus $200 thousand, or $0.01 per diluted share, in the prior-year quarter. Non-GAAP gross margin was 48.5% versus 37.5% a year ago, and bookings were $46.7 million versus $11.4 million in the prior-year quarter. Quarter-end backlog was $100.9 million, and effective backlog was $109.3 million as of November 1. For fiscal 2027, management raised revenue guidance to $150 million and reiterated expected non-GAAP net income of at least 20% of revenue for the full year.
Gayn Erickson framed the quarter as evidence that AI and data center demand is translating into production ramps across more customers and more applications. He emphasized that Aehr is seeing a broader pipeline than in the past, with more than a dozen customers across AI processors, silicon photonics, silicon carbide, GaN, and memory, which he said should reduce dependence on any single program. His tone was confident and constructive, especially around the benchmark AI processor opportunity, where he described the potential as one of the largest the company has ever pursued.
Chris Hsu focused on execution, backlog, capacity expansion, and the financial leverage in the model. He said the company added Sonoma shipping capacity from Southeast Asia, which can support more than 20 additional Sonoma systems per month, and that quarter-end backlog rose to $100.9 million despite $33 million of revenue. He also highlighted non-GAAP gross margin of 48.5%, operating expenses of $7.8 million, operating cash use of $3.1 million, and cash plus restricted cash of $105.1 million, noting the company remains debt free. He said the revenue guide increase to $150 million reflects backlog, expected demand, and production schedules, while margins for FY2027 should stay around the current range with quarter-to-quarter variation.
Analysts pressed management on the size and timing of the new wafer-level benchmark opportunity, and Erickson said the customer’s installation in Taiwan is expected in early calendar 2027, roughly in line with prior expectations, with production decisions possible a few months after validation. He also explained that the opportunity is driven by rising device complexity and the limits of package-level burn-in for mixed thermal environments. On competition, he contrasted Aehr’s wafer-level burn-in and Sonoma package-level systems with SLT and other test platforms, arguing that those alternatives are not equivalent to true burn-in. Analysts also asked about supply chain and backlog conversion; management said it has already expanded infrastructure, is working with subcontractors, and is not currently supply-limited, but is staying conservative on near-term orders.
The bull case from this call is that AI-driven burn-in demand appears to be broadening quickly across both wafer-level and package-level products, with several customer programs moving toward production. Management repeatedly emphasized record backlog, strong bookings, and expanded manufacturing capacity, while also saying consumables could become a larger part of the mix over time. If the benchmark AI customer converts and other qualification programs follow, Aehr believes the revenue base could become more diversified and less dependent on any one customer.
The main risks discussed were customer-timing variability, especially around the large benchmark AI processor program that still needs installation, validation, and a production decision after that. Management also noted that NAND opportunities are progressing more slowly than expected, and gross margin may fluctuate by quarter, with Q2 likely lower because of the Sonoma shipment mix. In addition, despite the strong outlook, the company acknowledged it is still in the process of scaling supply chain and manufacturing capacity to keep up with demand.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 95.1%
- Shares Outstanding
- 32.79M
- Float Shares
- 31.20M
of shares held by institutions
293 13F filers
Buy/sell ratio 0.36. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 2.70M | ▲ 38.30K |
| Vanguard Group Inc | 2.34M | ▲ 49.24K |
| Vanguard Capital Management LLC | 1.36M | ▲ 37.45K |
| Jpmorgan Chase & Co | 1.32M | ▲ 588.81K |
| Vanguard Portfolio Management LLC | 954.45K | ▼ 12.21K |
| Geode Capital Management, LLC | 893.06K | ▲ 17.55K |
| Goldman Sachs Group Inc | 849.62K | ▲ 39.59K |
| Driehaus Capital Management LLC | 803.62K | ▲ 565.20K |
| Fmr LLC | 774.99K | ▼ 231.84K |
| State Street Corp | 772.96K | ▲ 60.03K |
| Connor, Clark & Lunn Investment Management Ltd. | 716.80K | ▲ 46.04K |
| Arrowstreet Capital, Limited Partnership | 636.27K | ▲ 600.28K |
Held by 266 ETFs
Biggest fund positions in AEHR by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 18, 26 | POSEDEL RHEA J | other | 380 |
| Nov 18, 26 | POSEDEL RHEA J | other | 380 |
| Nov 1, 26 | SALAMONE ALBERTO | other | 204 |
| Oct 28, 26 | VIJAYRAO NARSING KRISHNA | other | 2,169 |
| Oct 28, 26 | VIJAYRAO NARSING KRISHNA | other | 0 |
| Oct 27, 26 | SPORCK ALISTAIR N | other | 188 |
| Oct 27, 26 | ROGERS VERNON | other | 197 |
| Oct 27, 26 | RICHMOND DONALD P. II | other | 145 |
| Oct 27, 26 | Erickson Gayn | other | 851 |
| Oct 27, 26 | ENGINEER ADIL | other | 202 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AEHR coverage
Recent articles, reports, and earnings notes.
Want a deeper read on AEHR?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI Demand
marketbeat.com · Nov 11
Aehr Test Systems Sees Unusually Large Options Volume (NASDAQ:AEHR)
defenseworld.net · Nov 5
AEHR Q1 Earnings Beat Estimates on AI Demand, Revenue Outlook Raised
zacks.com · Nov 3
Aehr Test Systems: 3 Key Takeaways for Long-Term Investors
fool.com · Nov 3
Why Aehr Test Systems Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
benzinga.com · Nov 3
Aehr Test Systems, Inc. (AEHR) Q1 2027 Earnings Call Transcript
seekingalpha.com · Nov 2
What Aehr Test Systems (AEHR) Said on Its Q1 Earnings Call
marketbeat.com · Nov 2
Aehr Test Systems Stock Pops After Q1 Results: Here's Why
benzinga.com · Nov 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
